Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Pediatr Pulmonol. 2021 Jul 16;56(9):2868–2878. doi: 10.1002/ppul.25559

Figure 4.

Figure 4.

Lung function and sputum biomass in patients born after January 1, 1997 and infected by different MRSA clusters. A. Lung function in 2017 (annual best FEV1 % predicted) is shown as a function of age. Patients with Cluster A MRSA are depicted by circles, Cluster B by diamonds. Two subjects with Cluster C MRSA are omitted. Generalized linear regression results are at bottom; advancing age and Cluster A MRSA were associated with lower lung function. B. Trends in FEV1 % predicted by MRSA cluster between 2011 and 2017. Symbols indicate mean FEV1 % predicted by MRSA types, Cluster A (circles), Cluster B (diamonds). Bars indicate standard deviation. The number of patients examined per year is given at bottom. The average FEV1 % predicted for patients with Cluster A MRSA decreased with time (slope −3.7% yr −1, P < 0.001). The average FEV1 % predicted for patients infected with Cluster B MRSA was stable (slope −0.5 % yr −1, P = 0.72). C-D. Quantitation of CF microorganisms in sputum from young patients infected by MRSA belonging to cluster A or cluster B. Each dot represents a different sputum culture. C. MRSA, D. P. aeruginosa. * P < 0.01 by Wilcoxon rank sum test